ONYX PHARMACEUTICALS INC 4
4 · ONYX PHARMACEUTICALS INC · Filed Aug 16, 2007
Insider Transaction Report
Form 4
GIOTTA GREGORY J
VP & Chief Legal Counsel
Transactions
- Sale
Common Stock
2007-08-14$32.00/sh−3,904$124,928→ 2,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2007-08-14−3,904→ 0 totalExercise: $10.52Exp: 2011-07-27→ Common Stock (3,904 underlying) - Exercise/Conversion
Common Stock
2007-08-14$10.52/sh+3,904$41,070→ 5,904 total
Footnotes (1)
- [F1]12.5% of the shares subject to the option become exercisable 6 months following the date of grant. The remaining shares become exercisable in equal monthly installments over the following 42 months for a total vesting schedule of 48 months.